These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3133344)

  • 1. Antimycoplasmal activities of the pseudomonic acids and structure-activity relationships of monic acid A derivatives.
    Banks RM; Donald AC; Hannan PC; O'Hanlon PJ; Rogers NH
    J Antibiot (Tokyo); 1988 May; 41(5):609-13. PubMed ID: 3133344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of monic acid A in pseudomonic acid A biosynthesis in Pseudomonas fluorescens.
    Mantle PG; Macgeorge KM
    Appl Microbiol Biotechnol; 1990 Sep; 33(6):709-11. PubMed ID: 1367487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and activity of nonhydrolyzable pseudomonic acid analogues.
    Klein LL; Yeung CM; Kurath P; Mao JC; Fernandes PB; Lartey PA; Pernet AG
    J Med Chem; 1989 Jan; 32(1):151-60. PubMed ID: 2491891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unified strategy for the synthesis of the C1-C14 fragment of marinolic acids, mupirocins, pseudomonic acids and thiomarinols: total synthesis of pseudomonic acid methyl monate C.
    Sridhar Y; Srihari P
    Org Biomol Chem; 2014 May; 12(18):2950-9. PubMed ID: 24691713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemistry of pseudomonic acid. Part 16. Aryl and heteroaryl ketone derivatives of monic acid.
    Abson A; Broom NJ; Coates PA; Elder JS; Forrest AK; Hannan PC; Hicks AJ; O'Hanlon PJ; Masson ND; Pearson ND; Pons JE; Wilson JM
    J Antibiot (Tokyo); 1996 Apr; 49(4):390-4. PubMed ID: 8642004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis reveals that all tailoring region genes are required for production of polyketide antibiotic mupirocin by pseudomonas fluorescens: pseudomonic acid B biosynthesis precedes pseudomonic acid A.
    Hothersall J; Wu J; Rahman AS; Shields JA; Haddock J; Johnson N; Cooper SM; Stephens ER; Cox RJ; Crosby J; Willis CL; Simpson TJ; Thomas CM
    J Biol Chem; 2007 May; 282(21):15451-61. PubMed ID: 17383964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. Amidines.
    de Zwart MA; van der Goot H; Timmerman H
    J Med Chem; 1989 Feb; 32(2):487-93. PubMed ID: 2913309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monic acid A: a biomarker in clinical intra-nasal mupirocin medication for MRSA decolonisation.
    Dare TO; Nicholls AW; Mantle PG
    Biomarkers; 2019 Mar; 24(2):131-133. PubMed ID: 30126316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. Amides.
    de Zwart MA; van der Goot H; Timmerman H
    J Med Chem; 1988 Apr; 31(4):716-22. PubMed ID: 3351847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimycoplasmal activity of oleuropein.
    Furneri PM; Marino A; Saija A; Uccella N; Bisignano G
    Int J Antimicrob Agents; 2002 Oct; 20(4):293-6. PubMed ID: 12385687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemistry of pseudomonic acid. 17. Dual-action C-1 oxazole derivatives of pseudomonic acid having an extended spectrum of antibacterial activity.
    Broom NJ; Cassels R; Cheng HY; Elder JS; Hannan PC; Masson N; O'Hanlon PJ; Pope A; Wilson JM
    J Med Chem; 1996 Aug; 39(18):3596-600. PubMed ID: 8784459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
    [No Abstract]   [Full Text] [Related]  

  • 13. How does Pseudomonas fluorescens, the producing organism of the antibiotic pseudomonic acid A, avoid suicide?
    Hughes J; Mellows G; Soughton S
    FEBS Lett; 1980 Dec; 122(2):322-4. PubMed ID: 6781934
    [No Abstract]   [Full Text] [Related]  

  • 14. Mupirocin W, a novel pseudomonic acid produced by targeted mutation of the mupirocin biosynthetic gene cluster.
    Cooper SM; Cox RJ; Crosby J; Crump MP; Hothersall J; Laosripaiboon W; Simpson TJ; Thomas CM
    Chem Commun (Camb); 2005 Mar; (9):1179-81. PubMed ID: 15726184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antimicrobial efficacy and structure activity relationship of novel carbohydrate fatty acid derivatives against Listeria spp. and food spoilage microorganisms.
    Nobmann P; Smith A; Dunne J; Henehan G; Bourke P
    Int J Food Microbiol; 2009 Jan; 128(3):440-5. PubMed ID: 19012983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonic acid. Part 1. The structure of pseudomonic acid A, a novel antibiotic produced by Pseudomonas fluorescens.
    Chain EB; Mellows G
    J Chem Soc Perkin 1; 1977; (3):294-309. PubMed ID: 402371
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudomonic acid. Part 3. Structure of pseudomonic acid B.
    Chain EB; Mellows G
    J Chem Soc Perkin 1; 1977; (3):318-24. PubMed ID: 402373
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro activity of mupirocin, a new topical agent against Staphylococcus aureus].
    Rosales Rodríguez M
    Enferm Infecc Microbiol Clin; 1990 Nov; 8(9):572-3. PubMed ID: 2129195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.
    Casewell MW; Hill RL
    J Antimicrob Chemother; 1985 May; 15(5):523-31. PubMed ID: 3924877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonic acid. Part 2. Biosynthesis of pseudomonic acid A.
    Feline TC; Jones RB; Mellows G; Phillips L
    J Chem Soc Perkin 1; 1977; (3):309-18. PubMed ID: 402372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.